3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
7
Unknown
5
Recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
2
Conditions
Stomatitis
2
Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Radiation Induced Xerostomia
1
Radiation Fibrosis Syndrome
1
Mouth Neoplasms
1
Lymphedema
1
Hematologic Neoplasms
1
Hand-Foot Syndrome
1
Graft vs Host Disease
1
Cognitive Dysfunction
1
Breast Cancer Lymphedema
1
Interventions
pembrolizumab
25
Cisplatin
17
Carboplatin
13
Radiotherapy
12
Cetuximab
9
Blood Specimen Collection
9
Docetaxel
8
Paclitaxel
7
Fluorouracil
7
Drug Therapy
7
toripalimab
6
tislelizumab
4
nimotuzumab
4
atezolizumab
4
Surveys and Questionnaires
4
Radiation
4
Chemoradiotherapy
4
fludarabine
3
Surgical Procedures, Operative
3
Standard of Care
3
Radiotherapy, Intensity-Modulated
3
Cyclophosphamide
3
Biopsy
3
130-nm albumin-bound paclitaxel
3
cemiplimab
2
avelumab
2
X-Rays
2
Tocopherols
2
Tiragolumab
2
Therapeutics
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Head and Neck Neoplasms
×
Low-Level Light Therapy
×
Clear all
NCT06708754
2026-03-30
PBM-LEF
NYU Langone Health
Phase NA
Recruiting
60 enrolled
NCT07387978
2026-02-04
PBM
Peter MacCallum Cancer Centre, Australia
Phase NA
Recruiting
30 enrolled